T. Nonomura

发表

Activation of c-Yes in hepatocellular carcinoma: a preliminary study.

H. Yoshiji, H. Usuki, T. Masaki, 2006, World journal of gastroenterology.

Antitumor effects of vitamins K1, K2 and K3 on hepatocellular carcinoma in vitro and in vivo.

H. Yoshiji, T. Masaki, S. Kuriyama, 2005, International journal of oncology.

Identification of c-Yes expression in the nuclei of hepatocellular carcinoma cells: involvement in the early stages of hepatocarcinogenesis.

H. Yoshiji, T. Masaki, S. Kuriyama, 2007, International journal of oncology.

Adenovirus-mediated gene transfer into rat livers: comparative study of retrograde intrabiliary and antegrade intraportal administration.

H. Yoshiji, T. Masaki, S. Kuriyama, 2005, Oncology reports.

Comparison study of the expressions of myristoylated alanine-rich C kinase substrate in hepatocellular carcinoma, liver cirrhosis, chronic hepatitis, and normal liver.

H. Yoshiji, H. Usuki, S. Kuriyama, 2005, International journal of oncology.

Vitamins K2, K3 and K5 exert antitumor effects on established colorectal cancer in mice by inducing apoptotic death of tumor cells.

H. Yoshiji, T. Masaki, S. Kuriyama, 2007, International journal of oncology.

Vitamins K2, K3 and K5 exert in vivo antitumor effects on hepatocellular carcinoma by regulating the expression of G1 phase-related cell cycle molecules.

H. Yoshiji, T. Masaki, S. Kuriyama, 2005, International journal of oncology.

Safe and efficient transgene expression in rat hepatocytes induced by adenoviral administration into the biliary tract.

H. Yoshiji, T. Masaki, S. Kuriyama, 2005, Oncology Report.